Profile picture

Doctor Kathy Stein

Novartis Pharma GmbH, Nuremberg (Germany)
Follow
Logo ESC

Contributor content

Different perspectives of patients and physicians on LDL-C target achievement in the treatment of hypercholesterolemia: results on secondary prevention from the German PROCYON survey
Presentation
Different perspectives of patients and physicians on LDL-C target achievement in the treatment of hypercholesterolemia: results on secondary prevention from the German PROCYON survey
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources